Risks of Herpes Zoster in Patients with Rheumatoid Arthritis According to Biologic Disease Modifying Therapy

OBJECTIVE: To evaluate whether the risks of herpes zoster (HZ) differed by biologics with different mechanisms of actions (MOAs) in older rheumatoid arthritis (RA) patients. METHODS: Using Medicare data from 2006–2011, among RA patients with prior biologic use and no history of cancer or other auto-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Care Res (Hoboken)
Hlavní autoři: Yun, Huifeng, Xie, Fenglong, Delzell, Elizabeth, Chen, Lang, Levitan, Emily B., Lewis, James D., Saag, Kenneth G, Beukelman, Timothy, Winthrop, Kevin, Baddley, John W., Curtis, Jeffrey R
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5765980/
https://ncbi.nlm.nih.gov/pubmed/25201241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22470
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky